CROI 2010 Back

Die 4 wichtigsten Arbeiten zu.....
Lopinavir/r (Kaletra®)

San Francisco, 18. 2. 2010

#153LB Efficacy of ART with NVP+TDF/FTC vs LPV/r+TDF/FTC among Antiretroviral-naïve Women in Africa: OCTANE Trial 2/ACTG A5208

James McIntyre*1, M Hughes2, J Mellors3, Y Zheng2, J Hakim4, A Asmelash5, F Conradie6, R Schooley7, J Currier8, S Lockman2,5,9, and A5208/OCTANE Study Team

1Chris Hani Baragwanath Hosp, Johannesburg, South Africa; 2Harvard Sch of Publ Hlth, Boston, MA, US; 3Univ of Pittsburgh Med Ctr, PA, US; 4Univ of Zimbabwe, Harare; 5Botswana-Harvard AIDS Inst, Gaborone; 6Univ of the Witwatersrand, Johannesburg, South Africa; 7Univ of California, San Diego, US; 8Univ of California, Los Angeles, US; and 9Brigham and Women`s Hosp, Boston, MA, US


#107LB Chronic Kidney Disease and Exposure to ART in a Large Cohort with Long-term Follow-up: The EuroSIDA Study

Ole Kirk*1, A Mocroft2, P Reiss3, S De Wit4, D Sedlacek5, M Beniowski6, J Gatell7, A Phillips2, B Ledergerber8, J Lundgren1,9, and for the EuroSIDA Study Group

1Copenhagen HIV Prgm, Univ of Copenhagen, Denmark; 2Royal Free and Univ Coll London Med Sch, UK; 3Academic Med Ctr, Univ of Amsterdam, The Netherlands; 4Ctr Hosp Univ Saint-Pierre, Brussels, Belgium; 5Charles Univ Hosp, Plzen, Czech Republic; 6Specialistic Hosp, Chorzow, Poland; 7Hosp Clin, Barcelona, Spain; 8Univ Hosp Zurich, Switzerland; and 9Rigshospitalet, Copenhagen, Denmark


# 620 Pharmacokinetic Interactions Between Buprenorphine/Naloxone and Once-Daily Lopinavir/Ritonavir

Douglas Bruce*1, F Altice1, D Moody2, G Morse3, L Andrews1, S-N Lin2, W Fang2, Q Ma3, and G Friedland1

1Yale Univ AIDS Prgm, New Haven, CT, US; 2Univ of Utah, Salt Lake City, US; and 3Univ of Buffalo, NY, US


# 588 Adherence-resistance Relationships for Lopinavir/ritonavir (LPV/r)-based Regimens in Treatment-experienced Subjects

Martin King*, R Rode, T Podsadecki, A Lawal, L Fredrick, and B Bernstein

Abbott Labs, Abbott Park, IL, US


# 877 Pharmacokinetics of Lopinavir/Ritonavir Crushed vs Whole Tablets in Children

H Diep1, Brookie Best*1, E Capparelli1, S Rossi1, M Farrell1, E Williams2, G Lee2, J van den Anker2, and N Rakhmanina2

1Univ of California, San Diego, US and 2Children’s Natl Med Ctr, Washington, DC, US


  CROI 2010Back

DAIG LogoDGI LogoDSTIG LogoPEG Logo

Meldungen

Ältere Meldungen weiter

Diese Website bietet aktuelle Informationen zu HIV/Aids sowie zur HIV/HCV-Koinfektion. Im Mittelpunkt stehen HIV-Test, Symptome und Auswirkungen der HIV-Infektion, Behandlung der HIV-Infektion, HIV-Medikamente mit Nebenwirkungen und Komplikationen, Aids, Hepatitis B und C. Ein Verzeichnis der Ärzte mit Schwerpunkt HIV ergänzt das Angebot.